(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one

Star0

DB07149ExperimentalSmall molecule

(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one: Overview.

Mechanism: Pharmacologically active on Glycogen synthase kinase-3 beta
Curator reviewed
Formula / weight: C₁₃H₁₄FN₅O · 275.2816 g/mol (avg)

Resolves to

Compound

ChEMBLCHEMBL524266PubChem16757525

Structure

InChIKeyLCBAQTCTQXHTJG-ZETCQYMHSA-NSMILES[H][C@]1(CCF)CNC(=O)C2=C1NC(=C2)C1=NC(N)=NC=C1

Targets

P49841GSK3BP50750CDK9P24941CDK2O00311CDC7P06493CDK1

What you can answer from here — as of April 02, 2025

5Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with (7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account